
All
101 Courses
Accreditation
Help About Us Home
Pain Management: Acute & Chronic
| Course Number |
LWH530
|
| Objectives |
At the end of this course, you will understand
many issues relating to acute and chronic pain. |
| Credit Hours and Fee |
3.0 CE Credit Hours with a fee of $24.00 |
| Instructor |
Rudolf Klimes, PhD (Indiana University), MPH
(Johns Hopkins University);
Adjunct Professor at Folsom Lake
College, Folsom CA. |
|
Welcome
to this
3-contact-hour Continuing Education course with instant online processing and
certification 24/7. Study the course below, take the 12-question
multiple-choice
TEST, register and pay online. If
you score 75% or above, you may print your CE certificate on your printer as
soon as you finish.
If you have difficulty printing your certificate,
click here..
You may retake the test once.
|
A. Pain, The Universal
Disorder
You know it at once. It may be the fiery
sensation of a burn moments after your finger
touches the stove. Or it's a dull ache above
your brow after a day of stress and tension. Or
you may recognize it as a sharp pierce in your
back after you lift something heavy.
It is pain. In its most benign form, it warns
us that something isn't quite right, that we
should take medicine or see a doctor. At its
worst, however, pain robs us of our
productivity, our well-being, and, for many of
us suffering from extended illness, our very
lives. Pain is a complex perception that differs
enormously among individual patients, even those
who appear to have identical injuries or
illnesses.
In 1931, the French medical missionary Dr.
Albert Schweitzer wrote, "Pain is a more
terrible lord of mankind than even death
itself." Today, pain has become the universal
disorder, a serious and costly public health
issue, and a challenge for family, friends, and
health care providers who must give support to
the individual suffering from the physical as
well as the emotional consequences of pain.
A Brief History of Pain
Ancient civilizations recorded on stone tablets
accounts of pain and the treatments used:
pressure, heat, water, and sun. Early humans
related pain to evil, magic, and demons. Relief
of pain was the responsibility of sorcerers,
shamans, priests, and priestesses, who used
herbs, rites, and ceremonies as their
treatments.
The Greeks and Romans were the first to
advance a theory of sensation, the idea that the
brain and nervous system have a role in
producing the perception of pain. But it was not
until the Middle Ages and well into the
Renaissance-the 1400s and 1500s-that evidence
began to accumulate in support of these
theories. Leonardo da Vinci and his
contemporaries came to believe that the brain
was the central organ responsible for sensation.
Da Vinci also developed the idea that the spinal
cord transmits sensations to the brain.
In the 17th and 18th centuries, the study of
the body-and the senses-continued to be a source
of wonder for the world's philosophers. In 1664,
the French philosopher René Descartes described
what to this day is still called a "pain
pathway." Descartes illustrated how particles of
fire, in contact with the foot, travel to the
brain and he compared pain sensation to the
ringing of a bell.
In the 19th century, pain came to dwell under
a new domain-science-paving the way for advances
in pain therapy. Physician-scientists discovered
that opium, morphine, codeine, and cocaine could
be used to treat pain. These drugs led to the
development of aspirin, to this day the most
commonly used pain reliever. Before long,
anesthesia-both general and regional-was refined
and applied during surgery.
"It has no future but itself," wrote the 19th
century American poet Emily Dickinson, speaking
about pain. As the 21st century unfolds,
however, advances in pain research are creating
a less grim future than that portrayed in
Dickinson’s verse, a future that includes a
better understanding of pain, along with greatly
improved treatments to keep it in check.
The Two Faces of Pain: Acute
and Chronic
What is pain? The International Association for
the Study of Pain defines it as: An
unpleasant sensory and emotional experience
associated with actual or potential tissue
damage or described in terms of such damage.
It is useful to distinguish between two basic
types of pain, acute and chronic, and they
differ greatly.
- Acute pain, for the
most part, results from disease,
inflammation, or injury to tissues. This
type of pain generally comes on suddenly,
for example, after trauma or surgery, and
may be accompanied by anxiety or emotional
distress. The cause of acute pain can
usually be diagnosed and treated, and the
pain is self-limiting, that is, it is
confined to a given period of time and
severity. In some rare instances, it can
become chronic.
- Chronic pain is widely
believed to represent disease itself. It can
be made much worse by environmental and
psychological factors. Chronic pain persists
over a longer period of time than acute pain
and is resistant to most medical treatments.
It can—and often does—cause severe problems
for patients.
The A to Z of Pain
Hundreds of pain syndromes or disorders make up
the spectrum of pain. There are the most benign,
fleeting sensations of pain, such as a pin
prick. There is the pain of childbirth, the pain
of a heart attack, and the pain that sometimes
follows amputation of a limb. There is also pain
accompanying cancer and the pain that follows
severe trauma, such as that associated with head
and spinal cord injuries. A sampling of common
pain syndromes follows, listed alphabetically.
Arachnoiditis is a condition in which
one of the three membranes covering the brain
and spinal cord, called the arachnoid membrane,
becomes inflamed. A number of causes, including
infection or trauma, can result in inflammation
of this membrane. Arachnoiditis can produce
disabling, progressive, and even permanent pain.
Arthritis. Millions of Americans
suffer from arthritic conditions such as
osteoarthritis, rheumatoid arthritis, ankylosing
spondylitis, and gout. These disorders are
characterized by joint pain in the extremities.
Many other inflammatory diseases affect the
body's soft tissues, including tendonitis and
bursitis.
Back pain has become the high price
paid by our modern lifestyle and is a
startlingly common cause of disability for many
Americans, including both active and inactive
people. Back pain that spreads to the leg is
called sciatica and is a very common condition
(see below). Another common type of back pain is
associated with the discs of the spine, the
soft, spongy padding between the vertebrae
(bones) that form the spine. Discs protect the
spine by absorbing shock, but they tend to
degenerate over time and may sometimes rupture.
Spondylolisthesis is a back condition
that occurs when one vertebra extends over
another, causing pressure on nerves and
therefore pain. Also, damage to nerve roots (see
Spine Basics in the
Appendix) is a serious condition, called
radiculopathy, that can be extremely
painful. Treatment for a damaged disc includes
drugs such as painkillers, muscle relaxants, and
steroids; exercise or rest, depending on the
patient's condition; adequate support, such as a
brace or better mattress and physical therapy.
In some cases, surgery may be required to remove
the damaged portion of the disc and return it to
its previous condition, especially when it is
pressing a nerve root. Surgical procedures
include discectomy, laminectomy, or spinal
fusion (see section on surgery in
How is Pain Treated?
for more information on these treatments).
Burn pain can be profound and poses an
extreme challenge to the medical community.
First-degree burns are the least severe; with
third-degree burns, the skin is lost. Depending
on the injury, pain accompanying burns can be
excruciating, and even after the wound has
healed patients may have chronic pain at the
burn site.
Central pain syndrome-see "Trauma"
below.
Cancer pain can accompany the growth
of a tumor, the treatment of cancer, or chronic
problems related to cancer's permanent effects
on the body. Fortunately, most cancer pain can
be treated to help minimize discomfort and
stress to the patient.
Headaches affect millions of
Americans. The three most common types of
chronic headache are migraines, cluster
headaches, and tension headaches. Each comes
with its own telltale brand of pain.
- Migraines are characterized by
throbbing pain and sometimes by other
symptoms, such as nausea and visual
disturbances. Migraines are more frequent in
women than men. Stress can trigger a
migraine headache, and migraines can also
put the sufferer at risk for stroke.
- Cluster headaches are
characterized by excruciating, piercing pain
on one side of the head; they occur more
frequently in men than women.
- Tension headaches are often
described as a tight band around the head.
Head and facial pain can be agonizing,
whether it results from dental problems or from
disorders such as cranial neuralgia, in which
one of the nerves in the face, head, or neck is
inflamed. Another condition, trigeminal
neuralgia (also called tic douloureux),
affects the largest of the cranial nerves (see
The Nervous Systems in
the Appendix) and is characterized by a
stabbing, shooting pain.
Muscle pain can range from an aching
muscle, spasm, or strain, to the severe
spasticity that accompanies paralysis. Another
disabling syndrome is fibromyalgia, a
disorder characterized by fatigue, stiffness,
joint tenderness, and widespread muscle pain.
Polymyositis, dermatomyositis, and
inclusion body myositis are painful
disorders characterized by muscle inflammation.
They may be caused by infection or autoimmune
dysfunction and are sometimes associated with
connective tissue disorders, such as lupus and
rheumatoid arthritis.
Myofascial pain syndromes affect
sensitive areas known as trigger points, located
within the body's muscles. Myofascial pain
syndromes are sometimes misdiagnosed and can be
debilitating. Fibromyalgia is a type of
myofascial pain syndrome.
Neuropathic pain is a type of pain
that can result from injury to nerves, either in
the peripheral or central nervous system (see
The Nervous Systems in
the Appendix). Neuropathic pain can occur in any
part of the body and is frequently described as
a hot, burning sensation, which can be
devastating to the affected individual. It can
result from diseases that affect nerves (such as
diabetes) or from trauma, or, because
chemotherapy drugs can affect nerves, it can be
a consequence of cancer treatment. Among the
many neuropathic pain conditions are diabetic
neuropathy (which results from nerve damage
secondary to vascular problems that occur with
diabetes); reflex sympathetic dystrophy
syndrome (see below), which can follow
injury; phantom limb and
post-amputation pain (see
Phantom Pain in the Appendix), which can
result from the surgical removal of a limb;
postherpetic neuralgia, which can occur
after an outbreak of shingles; and central
pain syndrome, which can result from trauma
to the brain or spinal cord.
Reflex sympathetic dystrophy syndrome,
or RSDS, is accompanied by burning pain and
hypersensitivity to temperature. Often triggered
by trauma or nerve damage, RSDS causes the skin
of the affected area to become
characteristically shiny. In recent years, RSDS
has come to be called complex regional pain
syndrome (CRPS); in the past it was often
called causalgia.
Repetitive stress injuries are muscular
conditions that result from repeated motions
performed in the course of normal work or other
daily activities. They include:
- writer's cramp, which affects musicians
and writers and others,
- compression or entrapment neuropathies,
including carpal tunnel syndrome, caused by
chronic overextension of the wrist and
- tendonitis or tenosynovitis, affecting
one or more tendons.
Sciatica is a painful condition caused
by pressure on the sciatic nerve, the main nerve
that branches off the spinal cord and continues
down into the thighs, legs, ankles, and feet.
Sciatica is characterized by pain in the
buttocks and can be caused by a number of
factors. Exertion, obesity, and poor posture can
all cause pressure on the sciatic nerve. One
common cause of sciatica is a herniated disc
(see Spine Basics in the
Appendix).
Shingles and other painful disorders
affect the skin. Pain is a common symptom of
many skin disorders, even the most common
rashes. One of the most vexing neurological
disorders is shingles or herpes zoster, an
infection that often causes agonizing pain
resistant to treatment. Prompt treatment with
antiviral agents is important to arrest the
infection, which if prolonged can result in an
associated condition known as postherpetic
neuralgia. Other painful disorders affecting
the skin include:
- vasculitis, or inflammation of
blood vessels;
- other infections, including herpes
simplex;
- skin tumors and cysts, and
- tumors associated with
neurofibromatosis, a neurogenetic
disorder.
Sports injuries are common. Sprains,
strains, bruises, dislocations, and fractures
are all well-known words in the language of
sports. Pain is another. In extreme cases,
sports injuries can take the form of costly and
painful spinal cord and head injuries, which
cause severe suffering and disability.
Spinal stenosis refers to a narrowing
of the canal surrounding the spinal cord. The
condition occurs naturally with aging. Spinal
stenosis causes weakness in the legs and leg
pain usually felt while the person is standing
up and often relieved by sitting down.
Surgical pain may require regional or
general anesthesia during the procedure and
medications to control discomfort following the
operation. Control of pain associated with
surgery includes presurgical preparation and
careful monitoring of the patient during and
after the procedure.
Temporomandibular disorders are
conditions in which the temporomandibular joint
(the jaw) is damaged and/or the muscles used for
chewing and talking become stressed, causing
pain. The condition may be the result of a
number of factors, such as an injury to the jaw
or joint misalignment, and may give rise to a
variety of symptoms, most commonly pain in the
jaw, face, and/or neck muscles. Physicians reach
a diagnosis by listening to the patient's
description of the symptoms and by performing a
simple examination of the facial muscles and the
temporomandibular joint.
Trauma can occur after injuries in the
home, at the workplace, during sports
activities, or on the road. Any of these
injuries can result in severe disability and
pain. Some patients who have had an injury to
the spinal cord experience intense pain ranging
from tingling to burning and, commonly, both.
Such patients are sensitive to hot and cold
temperatures and touch. For these individuals, a
touch can be perceived as intense burning,
indicating abnormal signals relayed to and from
the brain. This condition is called central
pain syndrome or, if the damage is in the
thalamus (the brain's center for processing
bodily sensations), thalamic pain syndrome.
It affects as many as 100,000 Americans with
multiple sclerosis, Parkinson's disease,
amputated limbs, spinal cord injuries, and
stroke. Their pain is severe and is extremely
difficult to treat effectively. A variety of
medications, including analgesics,
antidepressants, anticonvulsants, and electrical
stimulation, are options available to central
pain patients.
Vascular disease or injury-such as
vasculitis or inflammation of blood vessels,
coronary artery disease, and circulatory
problems-all have the potential to cause pain.
Vascular pain affects millions of Americans and
occurs when communication between blood vessels
and nerves is interrupted. Ruptures, spasms,
constriction, or obstruction of blood vessels,
as well as a condition called ischemia in which
blood supply to organs, tissues, or limbs is cut
off, can also result in pain.
How is Pain Diagnosed?
There is no way to tell how much pain a person
has. No test can measure the intensity of pain,
no imaging device can show pain, and no
instrument can locate pain precisely. Sometimes,
as in the case of headaches, physicians find
that the best aid to diagnosis is the patient's
own description of the type, duration, and
location of pain. Defining pain as sharp or
dull, constant or intermittent, burning or
aching may give the best clues to the cause of
pain. These descriptions are part of what is
called the pain history, taken by the physician
during the preliminary examination of a patient
with pain.
Physicians, however, do have a number of
technologies they use to find the cause of pain.
Primarily these include:
- Electrodiagnostic procedures
include electromyography (EMG),
nerve conduction studies, and evoked
potential (EP) studies. Information from
EMG can help physicians tell
precisely which muscles or nerves are
affected by weakness or pain. Thin needles
are inserted in muscles and a physician can
see or listen to electrical signals
displayed on an EMG machine. With nerve
conduction studies the doctor uses two
sets of electrodes (similar to those used
during an electrocardiogram) that are placed
on the skin over the muscles. The first set
gives the patient a mild shock that
stimulates the nerve that runs to that
muscle. The second set of electrodes is used
to make a recording of the nerve's
electrical signals, and from this
information the doctor can determine if
there is nerve damage. EP tests also
involve two sets of electrodes-one set for
stimulating a nerve (these electrodes are
attached to a limb) and another set on the
scalp for recording the speed of nerve
signal transmission to the brain.
- Imaging, especially magnetic
resonance imaging or MRI,
provides physicians with pictures of the
body's structures and tissues. MRI uses
magnetic fields and radio waves to
differentiate between healthy and diseased
tissue.
- A neurological examination in
which the physician tests movement,
reflexes, sensation, balance, and
coordination.
- X-rays produce pictures of the
body's structures, such as bones and joints.
How is Pain Treated?
The goal of pain management is to improve
function, enabling individuals to work, attend
school, or participate in other day-to-day
activities. Patients and their physicians have a
number of options for the treatment of pain;
some are more effective than others. Sometimes,
relaxation and the use of imagery as a
distraction provide relief. These methods can be
powerful and effective, according to those who
advocate their use. Whatever the treatment
regime, it is important to remember that pain is
treatable. The following treatments are
among the most common.
Acetaminophen is the basic ingredient
found in Tylenol® and its many generic
equivalents. It is sold over the counter, in a
prescription-strength preparation, and in
combination with codeine (also by prescription).
Acupuncture dates back 2,500 years and
involves the application of needles to precise
points on the body. It is part of a general
category of healing called traditional Chinese
or Oriental medicine. Acupuncture remains
controversial but is quite popular and may one
day prove to be useful for a variety of
conditions as it continues to be explored by
practitioners, patients, and investigators.
Analgesic refers to the class of drugs
that includes most painkillers, such as aspirin,
acetaminophen, and ibuprofen. The word analgesic
is derived from ancient Greek and means to
reduce or stop pain. Nonprescription or
over-the-counter pain relievers are generally
used for mild to moderate pain. Prescription
pain relievers, sold through a pharmacy under
the direction of a physician, are used for more
moderate to severe pain.
Anticonvulsants are used for the
treatment of seizure disorders but are also
sometimes prescribed for the treatment of pain.
Carbamazepine in particular is used to treat a
number of painful conditions, including
trigeminal neuralgia. Another antiepileptic
drug, gabapentin, is being studied for its
pain-relieving properties, especially as a
treatment for neuropathic pain.
Antidepressants are sometimes used for
the treatment of pain and, along with
neuroleptics and lithium, belong to a category
of drugs called psychotropic drugs. In addition,
anti-anxiety drugs called benzodiazepines also
act as muscle relaxants and are sometimes used
as pain relievers. Physicians usually try to
treat the condition with analgesics before
prescribing these drugs.
Antimigraine drugs include the
triptans- sumatriptan (Imitrex®), naratriptan (Amerge®),
and zolmitriptan (Zomig®)-and are used
specifically for migraine headaches. They can
have serious side effects in some people and
therefore, as with all prescription medicines,
should be used only under a doctor's care.
Aspirin may be the most widely used
pain-relief agent and has been sold over the
counter since 1905 as a treatment for fever,
headache, and muscle soreness.
Biofeedback is used for the treatment
of many common pain problems, most notably
headache and back pain. Using a special
electronic machine, the patient is trained to
become aware of, to follow, and to gain control
over certain bodily functions, including muscle
tension, heart rate, and skin temperature. The
individual can then learn to effect a change in
his or her responses to pain, for example, by
using relaxation techniques. Biofeedback is
often used in combination with other treatment
methods, generally without side effects.
Similarly, the use of relaxation techniques in
the treatment of pain can increase the patient's
feeling of well-being.
Capsaicin is a chemical found in chili
peppers that is also a primary ingredient in
pain-relieving creams (see
Chili Peppers, Capsaicin, and Pain in the
Appendix).
Chemonucleolysis is a treatment in
which an enzyme, chymopapain, is injected
directly into a herniated lumbar disc (see
Spine Basics in the
Appendix) in an effort to dissolve material
around the disc, thus reducing pressure and
pain. The procedure's use is extremely limited,
in part because some patients may have a
life-threatening allergic reaction to
chymopapain.
Chiropractic care may ease
back pain, neck pain, headaches, and
musculoskeletal conditions. It involves
"hands-on" therapy designed to adjust
the relationship between the body's structure
(mainly the spine) and its functioning.
Chiropractic spinal manipulation includes the
adjustment and manipulation of the joints and
adjacent tissues. Such care may also involve
therapeutic and rehabilitative exercises.
Cognitive-behavioral therapy
involves a wide variety of coping skills and
relaxation methods to help prepare for and cope
with pain. It is used for postoperative pain,
cancer pain, and the pain of childbirth.
Counseling can give a patient
suffering from pain much needed support, whether
it is derived from family, group, or individual
counseling. Support groups can provide an
important adjunct to drug or surgical treatment.
Psychological treatment can also help patients
learn about the physiological changes produced
by pain.
COX-2 inhibitors
may be effective for individuals with arthritis.
For many years scientists have wanted to develop
a drug that works as well as morphine but
without its negative side effects. Nonsteroidal
anti-inflammatory drugs (NSAIDs) work by
blocking two enzymes, cyclooxygenase-1 and
cyclooxygenase-2, both of which promote
production of hormones called
prostaglandins,
which in turn cause inflammation, fever, and
pain. The newer COX-2 inhibitors primarily block
cyclooxygenase-2 and are less likely to have the
gastrointestinal side effects sometimes produced
by NSAIDs.
In 1999, the Food and Drug Administration
approved a COX-2 inhibitor-celecoxib-for use in
cases of chronic pain. The long-term effects of
all COX-2 inhibitors are still being evaluated,
especially in light of new
information
suggesting that these drugs may increase the
risk of heart attack and stroke.
Patients taking any of the
COX-2 inhibitors should review their drug
treatment with their doctors.
Electrical stimulation, including
transcutaneous electrical stimulation (TENS),
implanted electric nerve stimulation, and deep
brain or spinal cord stimulation, is the
modern-day extension of age-old practices in
which the nerves of muscles are subjected to a
variety of stimuli, including heat or massage.
Electrical stimulation, no matter what form,
involves a major surgical procedure and is not
for everyone, nor is it 100 percent effective.
The following techniques each require
specialized equipment and personnel trained in
the specific procedure being used:
- TENS uses tiny electrical pulses,
delivered through the skin to nerve fibers,
to cause changes in muscles, such as
numbness or contractions. This in turn
produces temporary pain relief. There is
also evidence that TENS can activate subsets
of peripheral nerve fibers that can block
pain transmission at the spinal cord level,
in much the same way that shaking your hand
can reduce pain.
- Peripheral nerve stimulation uses
electrodes placed surgically on a carefully
selected area of the body. The patient is
then able to deliver an electrical current
as needed to the affected area, using an
antenna and transmitter.
- Spinal cord stimulation uses
electrodes surgically inserted within the
epidural space of the spinal cord. The
patient is able to deliver a pulse of
electricity to the spinal cord using a small
box-like receiver and an antenna taped to
the skin.
- Deep brain or intracerebral
stimulation is considered an extreme
treatment and involves surgical stimulation
of the brain, usually the thalamus. It is
used for a limited number of conditions,
including severe pain, central pain
syndrome, cancer pain, phantom limb pain,
and other neuropathic pains.
Exercise has come to be a prescribed
part of some doctors' treatment regimes for
patients with pain. Because there is a known
link between many types of chronic pain and
tense, weak muscles, exercise-even light to
moderate exercise such as walking or
swimming-can contribute to an overall sense of
well-being by improving blood and oxygen flow to
muscles. Just as we know that stress contributes
to pain, we also know that exercise, sleep, and
relaxation can all help reduce stress, thereby
helping to alleviate pain. Exercise has been
proven to help many people with low back pain.
It is important, however, that patients
carefully follow the routine laid out by their
physicians.
Hypnosis, first approved for medical
use by the American Medical Association in 1958,
continues to grow in popularity, especially as
an adjunct to pain medication. In general,
hypnosis is used to control physical function or
response, that is, the amount of pain an
individual can withstand. How hypnosis works is
not fully understood. Some believe that hypnosis
delivers the patient into a trance-like state,
while others feel that the individual is simply
better able to concentrate and relax or is more
responsive to suggestion. Hypnosis may result in
relief of pain by acting on chemicals in the
nervous system, slowing impulses. Whether and
how hypnosis works involves greater insight-and
research-into the mechanisms underlying human
consciousness.
Ibuprofen is a member of the aspirin
family of analgesics, the so-called nonsteroidal
anti-inflammatory drugs (see below). It is sold
over the counter and also comes in
prescription-strength preparations.
Low-power lasers have been used
occasionally by some physical therapists as a
treatment for pain, but like many other
treatments, this method is not without
controversy.
Magnets are increasingly popular with
athletes who swear by their effectiveness for
the control of sports-related pain and other
painful conditions. Usually worn as a collar or
wristwatch, the use of magnets as a treatment
dates back to the ancient Egyptians and Greeks.
While it is often dismissed as quackery and
pseudoscience by skeptics, proponents offer the
theory that magnets may effect changes in cells
or body chemistry, thus producing pain relief.
Narcotics (see Opioids, below).
Nerve blocks employ the use of drugs,
chemical agents, or surgical techniques to
interrupt the relay of pain messages between
specific areas of the body and the brain. There
are many different names for the procedure,
depending on the technique or agent used. Types
of surgical nerve blocks include neurectomy;
spinal dorsal, cranial, and trigeminal rhizotomy;
and sympathectomy, also called sympathetic
blockade (see Nerve Blocks
in the Appendix).
Nonsteroidal anti-inflammatory drugs (NSAIDs)
(including aspirin and ibuprofen) are widely
prescribed and sometimes called non-narcotic or
non-opioid analgesics. They work by reducing
inflammatory responses in tissues. Many of these
drugs irritate the stomach and for that reason
are usually taken with food. Although
acetaminophen may have some anti-inflammatory
effects, it is generally distinguished from the
traditional NSAIDs.
Opioids are derived from the poppy
plant and are among the oldest drugs known to
humankind. They include codeine and perhaps the
most well-known narcotic of all, morphine.
Morphine can be administered in a variety of
forms, including a pump for patient
self-administration. Opioids have a narcotic
effect, that is, they induce sedation as well as
pain relief, and some patients may become
physically dependent upon them. For these
reasons, patients given opioids should be
monitored carefully; in some cases stimulants
may be prescribed to counteract the sedative
side effects. In addition to drowsiness, other
common side effects include constipation,
nausea, and vomiting.
Physical therapy and rehabilitation
date back to the ancient practice of using
physical techniques and methods, such as heat,
cold, exercise, massage, and manipulation, in
the treatment of certain conditions. These may
be applied to increase function, control pain,
and speed the patient toward full recovery.
Placebos offer some individuals pain
relief although whether and how they have an
effect is mysterious and somewhat controversial.
Placebos are inactive substances, such as sugar
pills, or harmless procedures, such as saline
injections or sham surgeries, generally used in
clinical studies as control factors to help
determine the efficacy of active treatments.
Although placebos have no direct effect on the
underlying causes of pain, evidence from
clinical studies suggests that many pain
conditions such as migraine headache, back pain,
post-surgical pain, rheumatoid arthritis,
angina, and depression sometimes respond well to
them. This positive response is known as the
placebo effect, which is defined as the
observable or measurable change that can occur
in patients after administration of a placebo.
Some experts believe the effect is psychological
and that placebos work because the patients
believe or expect them to work. Others say
placebos relieve pain by stimulating the brain's
own analgesics and setting the body's
self-healing forces in motion. A third theory
suggests that the act of taking placebos
relieves stress and anxiety-which are known to
aggravate some painful conditions-and, thus,
cause the patients to feel better. Still,
placebos are considered controversial because by
definition they are inactive and have no actual
curative value.
R.I.C.E.-Rest, Ice, Compression,
and Elevation-are four components
prescribed by many orthopedists, coaches,
trainers, nurses, and other professionals for
temporary muscle or joint conditions, such as
sprains or strains. While many common orthopedic
problems can be controlled with these four
simple steps, especially when combined with
over-the-counter pain relievers, more serious
conditions may require surgery or physical
therapy, including exercise, joint movement or
manipulation, and stimulation of muscles.
Surgery, although not always an
option, may be required to relieve pain,
especially pain caused by back problems or
serious musculoskeletal injuries. Surgery may
take the form of a nerve block (see
Nerve Blocks in the
Appendix) or it may involve an operation to
relieve pain from a ruptured disc. Surgical
procedures for back problems include
discectomy or, when microsurgical techniques
are used, microdiscectomy, in which the
entire disc is removed; laminectomy, a
procedure in which a surgeon removes only a disc
fragment, gaining access by entering through the
arched portion of a vertebra; and spinal fusion,
a procedure where the entire disc is removed and
replaced with a bone graft. In a spinal
fusion, the two vertebrae are then fused
together. Although the operation can cause the
spine to stiffen, resulting in lost flexibility,
the procedure serves one critical purpose:
protection of the spinal cord. Other operations
for pain include rhizotomy, in which a
nerve close to the spinal cord is cut, and
cordotomy, where bundles of nerves within
the spinal cord are severed. Cordotomy is
generally used only for the pain of terminal
cancer that does not respond to other therapies.
Another operation for pain is the dorsal root
entry zone operation, or DREZ, in which
spinal neurons corresponding to the patient's
pain are destroyed surgically. Because surgery
can result in scar tissue formation that may
cause additional problems, patients are well
advised to seek a second opinion before
proceeding. Occasionally, surgery is carried out
with electrodes that selectively damage neurons
in a targeted area of the brain. These
procedures rarely result in long-term pain
relief, but both physician and patient may
decide that the surgical procedure will be
effective enough that it justifies the expense
and risk. In some cases, the results of an
operation are remarkable. For example, many
individuals suffering from trigeminal neuralgia
who are not responsive to drug treatment have
had great success with a procedure called
microvascular decompression, in which tiny blood
vessels are surgically separated from
surrounding nerves.
top
What is the Role of Age and Gender in Pain?
Gender and Pain
It is now widely believed that pain affects men
and women differently. While the sex hormones
estrogen and testosterone certainly play a role
in this phenomenon, psychology and culture, too,
may account at least in part for differences in
how men and women receive pain signals. For
example, young children may learn to respond to
pain based on how they are treated when they
experience pain. Some children may be cuddled
and comforted, while others may be encouraged to
tough it out and to dismiss their pain.
Many investigators are turning their
attention to the study of gender differences and
pain. Women, many experts now agree, recover
more quickly from pain, seek help more quickly
for their pain, and are less likely to allow
pain to control their lives. They also are more
likely to marshal a variety of resources-coping
skills, support, and distraction-with which to
deal with their pain.
Research in this area is yielding fascinating
results. For example, male experimental animals
injected with estrogen, a female sex hormone,
appear to have a lower tolerance for pain-that
is, the addition of estrogen appears to lower
the pain threshold. Similarly, the presence of
testosterone, a male hormone, appears to elevate
tolerance for pain in female mice: the animals
are simply able to withstand pain better. Female
mice deprived of estrogen during experiments
react to stress similarly to male animals.
Estrogen, therefore, may act as a sort of pain
switch, turning on the ability to recognize
pain.
Investigators know that males and females
both have strong natural pain-killing systems,
but these systems operate differently. For
example, a class of painkillers called kappa-opioids
is named after one of several opioid receptors
to which they bind, the kappa-opioid receptor,
and they include the compounds nalbuphine
(Nubain®) and butorphanol (Stadol®).
Research suggests that kappa-opioids provide
better pain relief in women.
Though not prescribed widely, kappa-opioids
are currently used for relief of labor pain and
in general work best for short-term pain.
Investigators are not certain why kappa-opioids
work better in women than men. Is it because a
woman's estrogen makes them work, or because a
man's testosterone prevents them from working?
Or is there another explanation, such as
differences between men and women in their
perception of pain? Continued research may
result in a better understanding of how pain
affects women differently from men, enabling new
and better pain medications to be designed with
gender in mind.
Pain in Aging and Pediatric
Populations: Special Needs and Concerns
Pain is the number one complaint of older
Americans, and one in five older Americans takes
a painkiller regularly. In 1998, the American
Geriatrics Society (AGS) issued guidelines *
for the management of pain in older people. The
AGS panel addressed the incorporation of several
non-drug approaches in patients' treatment
plans, including exercise. AGS panel members
recommend that, whenever possible, patients use
alternatives to aspirin, ibuprofen, and other
NSAIDs because of the drugs' side effects,
including stomach irritation and
gastrointestinal bleeding. For older adults,
acetaminophen is the first-line treatment for
mild-to-moderate pain, according to the
guidelines. More serious chronic pain conditions
may require opioid drugs (narcotics), including
codeine or morphine, for relief of pain.
Pain in younger patients also requires
special attention, particularly because young
children are not always able to describe the
degree of pain they are experiencing. Although
treating pain in pediatric patients poses a
special challenge to physicians and parents
alike, pediatric patients should never be
undertreated. Recently, special tools for
measuring pain in children have been developed
that, when combined with cues used by parents,
help physicians select the most effective
treatments.
Nonsteroidal agents, and especially
acetaminophen, are most often prescribed for
control of pain in children. In the case of
severe pain or pain following surgery,
acetaminophen may be combined with codeine.
*
Journal of the American Geriatrics Society
(1998; 46:635-651).
A Pain Primer: What Do We
Know About Pain?
We may experience pain as a prick, tingle,
sting, burn, or ache. Receptors on the skin
trigger a series of events, beginning with an
electrical impulse that travels from the skin to
the spinal cord. The spinal cord acts as a sort
of relay center where the pain signal can be
blocked, enhanced, or otherwise modified before
it is relayed to the brain. One area of the
spinal cord in particular, called the dorsal
horn (see section on Spine
Basics in the Appendix), is important in the
reception of pain signals.
The most common destination in the brain for
pain signals is the thalamus and from there to
the cortex, the headquarters for complex
thoughts. The thalamus also serves as the
brain's storage area for images of the body and
plays a key role in relaying messages between
the brain and various parts of the body. In
people who undergo an amputation, the
representation of the amputated limb is stored
in the thalamus. (For a discussion of the
thalamus and its role in this phenomenon, called
phantom pain, see section on
Phantom Pain in the Appendix.)
Pain is a complicated process that involves
an intricate interplay between a number of
important chemicals found naturally in the brain
and spinal cord. In general, these chemicals,
called neurotransmitters, transmit nerve
impulses from one cell to another.
There are many different neurotransmitters in
the human body; some play a role in human
disease and, in the case of pain, act in various
combinations to produce painful sensations in
the body. Some chemicals govern mild pain
sensations; others control intense or severe
pain.
The body's chemicals act in the transmission
of pain messages by stimulating
neurotransmitter receptors found on the
surface of cells; each receptor has a
corresponding neurotransmitter. Receptors
function much like gates or ports and enable
pain messages to pass through and on to
neighboring cells. One brain chemical of special
interest to neuroscientists is glutamate.
During experiments, mice with blocked glutamate
receptors show a reduction in their responses to
pain. Other important receptors in pain
transmission are opiate-like receptors. Morphine
and other opioid drugs work by locking on to
these opioid receptors, switching on
pain-inhibiting pathways or circuits, and
thereby blocking pain.
Another type of receptor that responds to
painful stimuli is called a nociceptor.
Nociceptors are thin nerve fibers in the skin,
muscle, and other body tissues, that, when
stimulated, carry pain signals to the spinal
cord and brain. Normally, nociceptors only
respond to strong stimuli such as a pinch.
However, when tissues become injured or
inflamed, as with a sunburn or infection, they
release chemicals that make nociceptors much
more sensitive and cause them to transmit pain
signals in response to even gentle stimuli such
as breeze or a caress. This condition is called
allodynia -a state in which pain is
produced by innocuous stimuli.
The body's natural painkillers may yet prove
to be the most promising pain relievers,
pointing to one of the most important new
avenues in drug development. The brain may
signal the release of painkillers found in the
spinal cord, including serotonin, norepinephrine,
and opioid-like chemicals. Many pharmaceutical
companies are working to synthesize these
substances in laboratories as future
medications.
Endorphins and enkephalins are
other natural painkillers. Endorphins may be
responsible for the "feel good" effects
experienced by many people after rigorous
exercise; they are also implicated in the
pleasurable effects of smoking.
Similarly, peptides, compounds that
make up proteins in the body, play a role in
pain responses. Mice bred experimentally to lack
a gene for two peptides called
tachykinins-neurokinin A and substance
P-have a reduced response to severe pain. When
exposed to mild pain, these mice react in the
same way as mice that carry the missing gene.
But when exposed to more severe pain, the mice
exhibit a reduced pain response. This suggests
that the two peptides are involved in the
production of pain sensations, especially
moderate-to-severe pain. Continued research on
tachykinins, conducted with support from the
NINDS, may pave the way for drugs tailored to
treat different severities of pain.
Scientists are working to develop potent
pain-killing drugs that act on receptors for the
chemical acetylcholine. For example, a
type of frog native to Ecuador has been found to
have a chemical in its skin called epibatidine,
derived from the frog's scientific name,
Epipedobates tricolor. Although highly
toxic, epibatidine is a potent analgesic and,
surprisingly, resembles the chemical nicotine
found in cigarettes. Also under development are
other less toxic compounds that act on
acetylcholine receptors and may prove to be more
potent than morphine but without its addictive
properties.
The idea of using receptors as gateways for
pain drugs is a novel idea, supported by
experiments involving substance P. Investigators
have been able to isolate a tiny population of
neurons, located in the spinal cord, that
together form a major portion of the pathway
responsible for carrying persistent pain signals
to the brain. When animals were given injections
of a lethal cocktail containing substance P
linked to the chemical saporin, this group of
cells, whose sole function is to communicate
pain, were killed. Receptors for substance P
served as a portal or point of entry for the
compound. Within days of the injections, the
targeted neurons, located in the outer layer of
the spinal cord along its entire length,
absorbed the compound and were neutralized. The
animals' behavior was completely normal; they no
longer exhibited signs of pain following injury
or had an exaggerated pain response.
Importantly, the animals still responded to
acute, that is, normal, pain. This is a critical
finding as it is important to retain the body's
ability to detect potentially injurious stimuli.
The protective, early warning signal that pain
provides is essential for normal functioning. If
this work can be translated clinically, humans
might be able to benefit from similar compounds
introduced, for example, through lumbar (spinal)
puncture.
Another promising area of research using the
body's natural pain-killing abilities is the
transplantation of chromaffin cells into the
spinal cords of animals bred experimentally to
develop arthritis. Chromaffin cells produce
several of the body's pain-killing substances
and are part of the adrenal medulla, which sits
on top of the kidney. Within a week or so, rats
receiving these transplants cease to exhibit
telltale signs of pain. Scientists, working with
support from the NINDS, believe the transplants
help the animals recover from pain-related
cellular damage. Extensive animal studies will
be required to learn if this technique might be
of value to humans with severe pain.
One way to control pain outside of the brain,
that is, peripherally, is by inhibiting hormones
called prostaglandins. Prostaglandins
stimulate nerves at the site of injury and cause
inflammation and fever. Certain drugs, including
NSAIDs, act against such hormones by blocking
the enzyme that is required for their synthesis.
Blood vessel walls stretch or dilate during a
migraine attack and it is thought that serotonin
plays a complicated role in this process. For
example, before a migraine headache, serotonin
levels fall. Drugs for migraine include the
triptans: sumatriptan (Imitrix®), naratriptan
(Amerge®), and zolmitriptan (Zomig®). They are
called serotonin agonists because they
mimic the action of endogenous (natural)
serotonin and bind to specific subtypes of
serotonin receptors.
Ongoing pain research, much of it supported
by the NINDS, continues to reveal at an
unprecedented pace fascinating insights into how
genetics, the immune system, and the skin
contribute to pain responses.
The explosion of knowledge about human
genetics is helping scientists who work in the
field of drug development. We know, for example,
that the pain-killing properties of codeine rely
heavily on a liver enzyme, CYP2D6, which helps
convert codeine into morphine. A small number of
people genetically lack the enzyme CYP2D6; when
given codeine, these individuals do not get pain
relief. CYP2D6 also helps break down certain
other drugs. People who genetically lack CYP2D6
may not be able to cleanse their systems of
these drugs and may be vulnerable to drug
toxicity. CYP2D6 is currently under
investigation for its role in pain.
In his research, the late John C. Liebeskind,
a renowned pain expert and a professor of
psychology at UCLA, found that pain can kill by
delaying healing and causing cancer to spread.
In his pioneering research on the immune system
and pain, Dr. Liebeskind studied the effects of
stress-such as surgery-on the immune system and
in particular on cells called natural killer
or NK cells. These cells are thought to
help protect the body against tumors. In one
study conducted with rats, Dr. Liebeskind found
that, following experimental surgery, NK cell
activity was suppressed, causing the cancer to
spread more rapidly. When the animals were
treated with morphine, however, they were able
to avoid this reaction to stress.
The link between the nervous and immune
systems is an important one. Cytokines, a type
of protein found in the nervous system, are also
part of the body's immune system, the body's
shield for fighting off disease. Cytokines can
trigger pain by promoting inflammation, even in
the absence of injury or damage. Certain types
of cytokines have been linked to nervous system
injury. After trauma, cytokine levels rise in
the brain and spinal cord and at the site in the
peripheral nervous system where the injury
occurred. Improvements in our understanding of
the precise role of cytokines in producing pain,
especially pain resulting from injury, may lead
to new classes of drugs that can block the
action of these substances.
What is the Future of Pain
Research?
In the forefront of pain research are scientists
supported by the National Institutes of Health (NIH),
including the NINDS. Other institutes at NIH
that support pain research include the National
Institute of Dental and Craniofacial Research,
the National Cancer Institute, the National
Institute of Nursing Research, the National
Institute on Drug Abuse, and the National
Institute of Mental Health. Developing better
pain treatments is the primary goal of all pain
research being conducted by these institutes.
Some pain medications dull the patient's
perception of pain. Morphine is one such drug.
It works through the body's natural pain-killing
machinery, preventing pain messages from
reaching the brain. Scientists are working
toward the development of a morphine-like drug
that will have the pain-deadening qualities of
morphine but without the drug's negative side
effects, such as sedation and the potential for
addiction. Patients receiving morphine also face
the problem of morphine tolerance, meaning that
over time they require higher doses of the drug
to achieve the same pain relief. Studies have
identified factors that contribute to the
development of tolerance; continued progress in
this line of research should eventually allow
patients to take lower doses of morphine.
One objective of investigators working to
develop the future generation of pain
medications is to take full advantage of the
body's pain "switching center" by formulating
compounds that will prevent pain signals from
being amplified or stop them altogether.
Blocking or interrupting pain signals,
especially when there is no injury or trauma to
tissue, is an important goal in the development
of pain medications. An increased understanding
of the basic mechanisms of pain will have
profound implications for the development of
future medicines. The following areas of
research are bringing us closer to an ideal pain
drug.
Systems and Imaging: The idea of
mapping cognitive functions to precise areas of
the brain dates back to phrenology, the now
archaic practice of studying bumps on the head.
Positron emission tomography (PET), functional
magnetic resonance imaging (fMRI), and other
imaging technologies offer a vivid picture of
what is happening in the brain as it processes
pain. Using imaging, investigators can now see
that pain activates at least three or four key
areas of the brain's cortex-the layer of tissue
that covers the brain. Interestingly, when
patients undergo hypnosis so that the
unpleasantness of a painful stimulus is not
experienced, activity in some, but not all,
brain areas is reduced. This emphasizes that the
experience of pain involves a strong emotional
component as well as the sensory experience,
namely the intensity of the stimulus.
Channels: The frontier in the search
for new drug targets is represented by channels.
Channels are gate-like passages found along the
membranes of cells that allow electrically
charged chemical particles called ions to pass
into the cells. Ion channels are important for
transmitting signals through the nerve's
membrane. The possibility now exists for
developing new classes of drugs, including pain
cocktails that would act at the site of channel
activity.
Trophic Factors: A class of "rescuer"
or "restorer" drugs may emerge from our growing
knowledge of trophic factors, natural chemical
substances found in the human body that affect
the survival and function of cells. Trophic
factors also promote cell death, but little is
known about how something beneficial can become
harmful. Investigators have observed that an
over-accumulation of certain trophic factors in
the nerve cells of animals results in heightened
pain sensitivity, and that some receptors found
on cells respond to trophic factors and interact
with each other. These receptors may provide
targets for new pain therapies.
Molecular Genetics: Certain genetic
mutations can change pain sensitivity and
behavioral responses to pain. People born
genetically insensate to pain-that is,
individuals who cannot feel pain-have a mutation
in part of a gene that plays a role in cell
survival. Using "knockout" animal models-animals
genetically engineered to lack a certain
gene-scientists are able to visualize how
mutations in genes cause animals to become
anxious, make noise, rear, freeze, or become
hypervigilant. These genetic mutations cause a
disruption or alteration in the processing of
pain information as it leaves the spinal cord
and travels to the brain. Knockout animals can
be used to complement efforts aimed at
developing new drugs.
Plasticity: Following injury, the
nervous system undergoes a tremendous
reorganization. This phenomenon is known as
plasticity. For example, the spinal cord is
"rewired" following trauma as nerve cell axons
make new contacts, a phenomenon known as
"sprouting." This in turn disrupts the cells'
supply of trophic factors. Scientists can now
identify and study the changes that occur during
the processing of pain. For example, using a
technique called polymerase chain reaction,
abbreviated PCR, scientists can study the genes
that are induced by injury and persistent pain.
There is evidence that the proteins that are
ultimately synthesized by these genes may be
targets for new therapies. The dramatic changes
that occur with injury and persistent pain
underscore that chronic pain should be
considered a disease of the nervous system, not
just prolonged acute pain or a symptom of an
injury. Thus, scientists hope that therapies
directed at preventing the long-term changes
that occur in the nervous system will prevent
the development of chronic pain conditions.
Neurotransmitters: Just as mutations
in genes may affect behavior, they may also
affect a number of neurotransmitters involved in
the control of pain. Using sophisticated imaging
technologies, investigators can now visualize
what is happening chemically in the spinal cord.
From this work, new therapies may emerge,
therapies that can help reduce or obliterate
severe or chronic pain.
Thousands of years ago, ancient peoples
attributed pain to spirits and treated it with
mysticism and incantations. Over the centuries,
science has provided us with a remarkable
ability to understand and control pain with
medications, surgery, and other treatments.
Today, scientists understand a great deal about
the causes and mechanisms of pain, and research
has produced dramatic improvements in the
diagnosis and treatment of a number of painful
disorders. For people who fight every day
against the limitations imposed by pain, the
work of NINDS-supported scientists holds the
promise of an even greater understanding of pain
in the coming years. Their research offers a
powerful weapon in the battle to prolong and
improve the lives of people with pain: hope.
Source:
http://www.ninds.nih.gov/disorders/chronic_pain/detail_chronic_pain.htm
B.
Management of Cancer Pain
|
Summary
Evidence Report/Technology Assessment: Number 35
Please Note: The evidence report this
summary was derived from has not been updated within the past 5
years and is therefore no longer considered current. It
is maintained for archival purposes only.
Under its
Evidence-based Practice Program, the Agency for Healthcare
Research and Quality (AHRQ) is developing scientific information
for other agencies and organizations on which to base clinical
guidelines, performance measures, and other quality improvement
tools. Contractor institutions review all relevant scientific
literature on assigned clinical care topics and produce evidence
reports and technology assessments, conduct research on
methodologies and the effectiveness of their implementation, and
participate in technical assistance activities.
Overview /
Reporting the Evidence / Patient
Population and Settings / Methods /
Findings / Future
Research / Availability of Full
Report
Overview
Pain related to cancer affects the lives of large numbers of
patients and their families. The topic of cancer-related pain
was selected by the Agency for Healthcare Research and Quality (AHRQ)
in response to a request from the American Pain Society. In
framing this request, the American Pain Society observed that a
significant amount of scientific evidence had been published on
this topic since the 1994 release of the clinical practice
guideline Management of Cancer Pain.
This evidence report, however, is a literature synthesis and
not a clinical practice guideline or a survey of current
practice. It is intended to provide background information and
summaries of evidence for use by varied groups, including
primary care practitioners, nurses, pharmacists, physical
therapists, specialists in oncology, pain treatment, or other
disciplines, as well as policy makers. We reviewed the published
literature on the epidemiology of cancer pain and its relief and
also summarized predominantly randomized controlled trials so as
to gauge the efficacy of major treatments.
Return to Contents
Reporting the Evidence
The New
England Medical Center Evidence-based Practice Center (EPC)
staff, along with members of a panel of technical experts
including representatives from seven professional organizations,
developed the questions addressed in this report. These
organizations include the American Cancer Society, American
College of Physicians, American Pain Society, American Society
of Clinical Oncology, American Society of Anesthesiologists,
American Society of Health-System Pharmacists, and the Oncology
Nursing Society. Additional comments on the questions were
solicited from the American Academy of Family Physicians,
American Academy of Neurology, American Academy of Pain
Medicine, American Physical Therapy Association, Hospice and
Palliative Nurses Association, and Hospice Association of
America.
Patient Population and Settings
Patients with cancer-related pain were the subjects of
epidemiologic studies and controlled clinical trials. In the
present literature review, we define cancer-related pain as pain
caused by the disease or its treatment, such as surgery,
radiation therapy, or chemotherapy. Patients with
post-mastectomy pain were included, as were patients with pain
resulting from the side effects of anti-tumor treatment, such as
mucositis. Patients with cancer often experience pain from
causes unrelated to cancer, and treatment of such pain cannot be
omitted from their care. We did not, however, include trials
exclusively concerned with the treatment of acute postoperative
pain.
Methods
We performed a systematic review of the best available
evidence to address the above questions. Cancer disease burden
and the prevalence of cancer-related pain were estimated from
epidemiologic surveys. MEDLINE, CancerLit, and Cochrane
Controlled Trials Registry databases between 1966 and December
1998 were searched using a sensitive search strategy for
English-language human studies. Titles and abstracts of the
retrieved citations were manually screened to identify
potentially relevant studies. We consulted the technical experts
and colleagues and examined the bibliographies of selected
review articles and published meta-analyses on this subject for
additional references.
We extracted data from primary clinical studies that met
inclusion criteria to create an evidence table for each of the
major questions or subquestions, as appropriate. Randomization
of subjects into treatment and control groups (that do not get
the experimental treatment) in order to minimize the effect of
confounding variables is especially important in clinical trials
of interventions for pain relief, as is the use of "blind"
studies in which the subject alone (single-blind) or both the
investigator and the subject (double-blind) are unaware of the
specific treatment being applied. A multidimensional evidence
grading scale (internal validity, applicability, study size, and
effect size) was used to denote the quality of individual
studies, and the quality of the evidence pertinent to each of
the questions was summarized. Other details of the included
trials, such as the method of randomization and whether or what
type of blind study were examined.
Studies that met the inclusion criteria for meta-analysis
within each subquestion were combined using a random effects
model. For most questions, meta-analysis was not possible.
Therefore, for each question we supplemented the evidence
grading of relevant trials with a narrative summary of those
trials. At the request of AHRQ, we supplemented the above
evidence by examining results from 100 nonrandomized comparative
studies to address questions for which evidence from randomized
controlled trials was lacking.
Our search strategy identified over 19,000 titles. After a
series of screening processes, 24 epidemiologic surveys and 189
randomized controlled trials of treatments qualified for
inclusion in this report.
Findings
The overall methodological quality and reporting of treatment
studies in this field compare unfavorably with those of other
high-impact conditions. The average numbers of patients in
trials of primary analgesics—non-steroidal anti-inflammatory
drugs (NSAIDs) and opioids—were 84 and 68 (range 24 to 180 and
10 to 699, respectively). Studies of biphosphonates enrolled an
average of 111 patients (range 13 to 614). Trials of the
palliative use of primary cancer treatment
modalities—chemotherapy and radiotherapy—enrolled an average of
226 patients (range 38 to 1,016). Twenty-six out of 41 studies
in the group of opioid versus opioid comparisons were crossover
trials, in which the carryover effect from an earlier treatment
might be a problem due to an inadequate washout interval.
The primary outcome of pain intensity or pain relief is
subjective and has long been recognized to be susceptible to
bias in studies that are not blinded to the investigators and
patients. Particularly in analgesic trials, inclusion of control
treatments (either active or placebo) helps prevent
overestimation of treatment effects. Ethical considerations are
often advanced for the absence of placebo controls in cancer
pain trials, yet some trials were able ethically to employ
placebo controls by allowing patients ready access to medication
if needed ("rescue" medication).
The number of possible meta-analyses was limited by
heterogeneity of interventions and outcomes reported, and
incomplete reporting (such as absent data on variability of the
outcome estimates). Most studies do not specify whether pain is
assessed at rest, or with movement, or reflects breakthrough
episodes of increased intensity. Reporting on broad categories
of probable mechanism of pain, i.e., nociceptive or neuropathic,
was inconsistent.
Specific Questions
1. What are the epidemiological characteristics of
cancer-related pain, including pain caused by cancer, by the
side effects of cancer treatment, and by procedures used to
treat cancer?
Epidemiologic evidence on the incidence and prevalence of
cancer, on the incidence of cancer-related pain, and on the
likelihood of increasing pain intensity with advancing cancer
stage indicates that cancer pain adds substantially to the
already considerable national disease burden of cancer.
Minorities, women, and the elderly may be at greater risk for
undertreatment of pain. Survey data for the most part do not
distinguish between different etiologies and mechanisms of
cancer pain. Prevalence data imply that the number of patients
enrolled in methodologically sound trials of cancer pain relief
is a tiny fraction of those receiving care. Relatively few
subjects are enrolled per trial, and the total number of
published randomized controlled trials relative to patients
under care is much lower than for nearly all other high-impact,
costly conditions.
2. What is the relative efficacy of analgesics
currently used for cancer pain?
The number of randomized controlled trials evaluating
analgesic drugs for cancer pain relief is small, although
increasing. Direct interclass comparisons of efficacy are
possible between opioids and NSAIDs. The included trials do not
differentiate the relative efficacy of these two types of agents
administered through various routes to patients with mild,
moderate, or severe cancer pain.
There is evidence of an opioid dose-sparing effect from
co-administration of an NSAID but no consistent reduction in
side effects from co-administration. Placebo controls,
particularly in analgesic trials, are valuable to prevent
overestimation of treatment effects, yet for ethical reasons
such controls are rare in cancer pain trials. The heterogeneity
of existing trials precludes meta-analyses to address most
subquestions.
Ten studies addressed the relative analgesic efficacy of
various NSAIDs versus other NSAIDs or placebo. Of these, only
one study disclosed a significant difference in analgesic
efficacy between two NSAIDs. These 10 studies could not be
combined due to heterogeneity in the outcomes assessed, drug
doses and schedules compared, and study duration.
Trials to compare the efficacy of NSAIDs versus "weak"
opioids (i.e., opioids commonly prescribed for mild to moderate
pain) reveal no difference in analgesic efficacy between these
two classes of agents, even when the latter are co-administered
with the same NSAID tested in the former arm. These trials
enroll relatively small numbers of patients and follow them for
intervals of hours to days and only occasionally for periods as
long as 2 weeks. Many examine drugs not available in the United
States or not generally employed for cancer pain relief (e.g.,
pentazocine).
Our efforts to strengthen such evidence by examining
nonrandomized trials were not fruitful. One randomized
controlled trial evaluated oral transmucosal fentanyl citrate
for breakthrough pain (using a study design in which rescue
doses of morphine were available) and demonstrated its
superiority to placebo. We found no randomized controlled trials
addressing analgesic efficacy and safety of NSAIDs selective for
the cyclooxygenase-2 isozyme in treating cancer pain.
3. Are different analgesic drug formulations and
routes of administration associated with different patient
preferences or efficacy rates?
Published trials within the NSAID and, separately, opioid
drug classes demonstrate no differences in efficacy between oral
tablets or rectal suppositories within each class. Limited data
suggest that parenteral (intramuscular or intravenous)
administration offers no advantage from a purely analgesic
standpoint over enteral administration.
However, the included studies do not evaluate relative speed
of onset using the two routes, which for many drugs is known to
be more rapid after parenteral than enteral administration. For
opioids, eight included trials compared oral controlled-release
morphine with oral immediate-release morphine solution and none
found differences with respect to reduced pain intensity or
increased pain relief. These studies enrolled a total of 344
patients with a wide range of cancer types and pain types, of
which 271 were evaluated (79 percent). The majority of these
trials were double-blind but their results still may not be
reliable because of high dropout rates (10 to 40 percent).
Because these eight studies addressed the same question using
roughly comparable methods, we were able to perform a
meta-analysis using average pain intensity (during 4 to 14 days
of treatment) as the outcome of interest. No difference in pain
relief was found between controlled-release morphine and
immediate-release morphine solution. The decrease in dose
frequency accomplished by controlled-release formulations (transdermal,
oral, or rectal) is an implicit advantage of these dosage forms.
Four studies addressed comparative efficacy and adverse
effects of oral versus rectal administration of morphine. The
generalizability of the results is limited by the small numbers
of subjects in each study. Three of these four studies found no
difference in efficacy and the fourth observed small but
significant differences in onset of pain relief and duration of
analgesia, both in favor of the rectal route. No differences
with respect to adverse effects were observed between the two
routes in three studies, but in the fourth, patients receiving
rectal morphine had lower nausea scores. Two of these four
studies compared oral and rectal administration of the same
formulation (controlled-release morphine tablets) and provided
combinable data on pain scores. A meta-analysis of
between-treatment differences in average pain intensity
throughout each study's duration (4 to 14 days) showed that pain
intensity did not differ between the two study arms. One study
compared controlled-release rectal suppositories with
subcutaneous morphine and reported no differences in overall
pain scores, sedation or nausea, or rescue analgesic intake.
These negative conclusions should not be taken to mean that
individual patients do not benefit from the selection of one
route versus another in specific clinical contexts (e.g., by
employing suppositories or transdermal administration when
dysphagia limits oral dosing). Insufficient information exists
to reveal differences in relative side effects or patient
preference for either route.
4. What is the relative analgesic efficacy of
palliative pharmacological (chemotherapy, biphosphonates, or
calcitonin) and nonpharmacological cytotoxic or cytostatic
(radiation therapy or radionuclide) therapy?
We found 31 studies, including 153samarium-EDTMP,
etidronate, aminohydroxypropylidene biphosphonate (ADP,
pamidronate), salmon calcitonin, and clodronate. The
biphosphonate trials are quite heterogeneous, with differing
inclusion criteria, concomitant medical and radiotherapeutic
treatments, disease categories, dosage regimens, choice of
agent, and duration of followup. Methods to assess analgesic
efficacy in these trials ranged from analgesic intake to the
"requirement" for palliative radiation therapy.
Most studies showed a positive effect, some showed no effect,
and no study showed a detrimental effect of biphosphonate
therapy on skeletal symptoms of metastatic disease or myeloma.
Positive effects appeared harder to demonstrate in the presence
of concurrent chemotherapy, such as estramustine, which itself
might have a favorable effect on tumor progression and hence
bone symptoms.
Therefore, the literature in the aggregate suggests that
biphosphonates reduce pain due to bony involvement by tumor,
although the magnitude of this benefit may be reduced when
biphosphonate therapy is delivered in conjunction with other
tumor-directed therapies that may in themselves reduce such
symptoms.
Two studies compared strontium-89 with inactive strontium and
external radiotherapy, respectively, for bone pain. Strontium-89
was more effective than placebo (inactive strontium) and equally
effective as external radiation.
The literature on analgesic effects of various chemotherapy
and hormonal therapy regimens on pain is heterogeneous with
respect to inclusion criteria, therapeutic regimens, and methods
employed to assess analgesic efficacy. The use of analgesic
medication is reported in some studies, but in most, the
consumption of analgesics is not recorded. In only one
chemotherapy trial and in no hormonal therapy trial was there a
significant difference in pain-related outcome between treatment
arms.
Fourteen trials, involving a total of 3,859 patients,
compared fractional dosing schedules of external radiotherapy to
relieve pain from bony metastases. Although external radiation
as a modality is effective in decreasing pain, no trial found
more than a transient, unsustained difference in pain between
fractionation schedules. Meta-analysis was not possible due to
heterogeneity of dosing schedules, variability in the anatomic
sites and fields treated, and outcomes assessed. Short courses
of palliative treatment with higher doses appear to yield
results similar to longer courses that deliver a lower dose per
treatment. Even single-dose (i.e., unfractionated) radiation
appears to have similar effects on bone pain as fractionated
dosing, although the minimal total dose of radiation to provide
pain relief has not yet been determined.
5. What is the relative efficacy of current adjuvant
(nonpharmacological/noninvasive) physical or psychological
(relaxation, massage, heat and cold, music, and exercise)
treatments in the management of cancer-related pain?
The number of studies is small, and variability as to types
of intervention precludes any broad conclusions. Studies
evaluated different interventions applied to patients, medical
staff, and the community at large. Also, different types of pain
seemed to be addressed, although specifics were not always
provided.
Only a few randomized studies examine hypnosis in conjunction
with cognitive behavioral techniques in the context of acute
procedure-related pain and oral mucositis pain after bone marrow
transplant. They include studies in the pediatric and adult age
groups. Hypnosis seems to help with both procedural and
mucositis-related pain. Cognitive behavioral treatments may also
be helpful. More studies are needed, with larger numbers of
patients and with control groups.
6. What is the relative efficacy of current invasive
surgical and nonsurgical treatments, such as acupuncture, nerve
blocks, and neuroablation, for the treatment of cancer-related
pain?
The evidence available to answer these questions is, with few
exceptions, in the form of case series that do not use control
groups. Sufficient randomized controlled trials on neurolytic
celiac plexus block (NCPB) for pain relief in pancreatic and
other visceral cancers were identified to indicate the efficacy
of this modality. NCPB lowered pain scores or produced a
prolonged dose-sparing effect on analgesic drug requirement.
The near absence of randomized or controlled trials on the
efficacy of spinally administered opioids or other agents led us
to retrieve nonrandomized reports in an effort to estimate the
efficacy of this modality. These supplemental reports, although
positive, were case series without control groups and hence did
not yield data on relative efficacy of the spinal versus
systemic routes of drug administration.
Similarly, the efficacy of ablative neurosurgical
interventions, such as cordotomy or rhizotomy, was addressed
only in case series. No included trials addressed the efficacy
of acupuncture.
Future Research
Randomized controlled trials establish that many current
treatment modalities can individually reduce cancer pain. These
trials constitute 1 percent of the published literature on
cancer pain, enroll one in 10,000 patients at risk for cancer
pain in industrialized countries, are often heterogeneous, and
use poor methodology. Leading investigators in the area of
cancer pain relief have repeatedly called for improving the
quality of trials in this area. The quantity and quality of
scientific evidence on cancer pain relief still, however,
compare unfavorably with the great deal that is known about
other high-impact conditions, including cancer itself. In the
current era of patient-centered care, closing this gap should be
a high research priority.
Quality of life has not been uniformly assessed in trials of
analgesic drugs and nondrug interventions for cancer pain.
Limited evidence from the retrieved trials supports the position
that optimal analgesia benefits many dimensions of the quality
of life. Advances in quality-of-life assessment and insights
from research on chronic noncancer pain into the relationships
among pain, disability, and impairment offer the opportunity to
understand these interactions in the context of cancer pain.
Carefully designed trials with cancer pain relief as a
primary outcome are required in patients with well-defined
disease and pain. Such trials must conform to rising
expectations for clinical trials in general. High-quality trials
of cancer pain relief should:
- Enroll greater numbers of patients for longer
intervals than has generally been true in the past.
- Be blind and apply active placebos when
appropriate or use uniform control treatments otherwise.
- Employ adequate between-arm washout intervals
and consider advancing disease state in crossover trials.
- Assess side effects, pain mechanisms, and rest,
incident, or breakthrough pain in a standardized, combinable
fashion.
To design and conduct such trials will be challenging,
particularly for complementary therapies or infrequent
interventions such as spinal drug administration, but such
trials are necessary to refine our understanding of widely
employed interventions.
Investigations of cancer pain and its control should seek to
evaluate the influence of gender, race, age, psychosocial
context, ethnicity, and culture on the experience and report of
pain. The influence of such factors should also be examined
during studies aimed at defining the efficacy of specific
treatments and their associated side effects. Small-scale,
short-term randomized controlled trials that establish treatment
efficacy for purposes of Food and Drug Administration approval
are not designed to prove effectiveness as would larger scale,
long-term applications in the treatment of cancer pain relief.
To meet this need, outcomes research can provide valuable data
that are not feasible to acquire through controlled trials.
Until large, high-quality trials are accomplished and
accepted as definitive, systematic reviews of the best available
evidence on cancer pain control are required. Such reviews are
necessary to provide a foundation to guide current treatment and
future investigation. Increasing numbers of systematic reviews
on pain, palliative treatments, and supportive care are now
appearing through groups such as the Cochrane Collaboration, a
nonprofit organization that assembles, disseminates, and updates
the best available evidence on the effects of health care
interventions. Frequent updating of such reviews will be
necessary to keep pace with the accelerating number of cancer
pain relief trials. Of equal importance to the synthesis of the
best available evidence in the field is the dissemination of the
evidence to students, health care professionals, patients, and
their families and evaluation of the most effective educational
interventions.
Many clinical questions remain unanswered, and many
preclinical insights have not been translated into practice due
to a lack of high-quality evidence. In part, this lack of
evidence is due to the funding structure of trials that
emphasizes investigation of commercially viable products. Drug
interactions during long-term cancer pain treatment require
clarification. It is unclear whether a mechanism-based approach
to diagnosing and relieving each component of pain in an
individual is more effective than an empiric regimen in which
each patient's treatment is based on pain intensity alone.
Another key unanswered question is how to optimally combine drug
with nondrug therapies, given that the latter are safe and
inexpensive. Despite the importance of pediatric cancer pain
control, almost no analgesic drug trials focus on children.
Nearly two decades ago, the widely disseminated World Health
Organization's "three-step analgesic ladder" of stratified
therapy (use of an NSAID, addition of a "weak" opioid, or
substitution of the latter with a strong opioid) reflected the
best available evidence for cancer-related pain control. Its
effectiveness has been documented in large case series. Yet a
multiplicity of effective drug and nondrug options for cancer
pain relief is now available in the United States and other
industrialized countries. Optimally matching the options for
cancer pain control with individual needs, preferences, and
likely responses may require evolution of the three-step
analgesic ladder into an "elevator" that delivers patients
promptly and with ease to their chosen destinations within a
multi-storied edifice, and "escalators" to reposition them
subsequently between nearby levels.
Comprehensive, credible data that address individual
variations in preferences for, responses to, and costs incurred
by these options are a foundation for potential evidence-based
approaches to cancer pain control, but are presently sparse. For
example, the spinal route of analgesia is widely employed but
much remains to be learned about optimal patient selection, the
comparative efficacy of spinal drug infusion versus systemic
drug administration, and the selection of initial or secondary
agents or combinations. It is now time to apply equally
high-quality methods to questions in cancer pain relief as in
cancer treatment, particularly accrual of adequate numbers of
patients for clinical trials. Consumers, clinicians, and
policymakers must all be participants in this process.
|
Source:
http://www.ahrq.gov/clinic/epcsums/canpainsum.htm
C. What Are the Causes of
Back Pain?
There are many causes of back pain. Mechanical problems with
the back itself can cause pain. Examples are:
- Disc breakdown
- Spasms
- Tense muscles
- Ruptured discs
Injuries from sprains, fractures, accidents, and falls can
result in back pain.
Back pain can also occur with some conditions and diseases,
such as:
- Scoliosis
- Spondylolisthesis
- Arthritis
- Spinal stenosis
- Pregnancy
- Kidney stones
- Infections
- Endometriosis
- Fibromyalgia
Other possible causes of back pain are infections, tumors, or
stress.
Can Back Pain Be Prevented?
The best things you can do to prevent back pain are:
- Exercise often and keep your back muscles strong.
- Maintain a healthy weight or lose weight if you weigh
too much. To have strong bones, you need to get enough
calcium and vitamin D every day.
- Try to stand up straight and avoid heavy lifting when
you can. If you do lift something heavy, bend your legs and
keep your back straight.
When Should I See a Doctor for Pain?
You should see a doctor if you have:
- Numbness or tingling
- Severe pain that does not improve with rest
- Pain after a fall or an injury
- Pain plus any of these problems:
- Trouble urinating
- Weakness
- Numbness in your legs
- Fever
- Weight loss when not on a diet.
How Is Back Pain Diagnosed?
To diagnose back pain, your doctor will take your medical
history and do a physical exam. Your doctor may order other
tests, such as:
- X rays
- Magnetic resonance imaging (MRI)
- Computed tomography (CT) scan
- Blood tests.
Medical tests may not show the cause of your back pain. Many
times, the cause of back pain is never known. Back pain can get
better even if you do not know the cause.
What Is the Difference Between Acute and Chronic Pain?
Acute pain starts quickly and lasts less than 6 weeks. It is
the most common type of back pain. Acute pain may be caused by
things like falling, being tackled in football, or lifting
something heavy. Chronic pain lasts for more than 3 months and
is much less common than acute pain.
How Is Back Pain Treated?
Treatment for back pain depends on what kind of pain you
have. Acute back pain usually gets better without any treatment,
but you may want to take acetaminophen, aspirin, or ibuprofen to
help ease the pain. Exercise and surgery are not usually used to
treat acute back pain.
Following are some types of treatments for chronic back pain.
Hot or Cold Packs (or Both)
Hot or cold packs can soothe sore, stiff backs. Heat reduces
muscle spasms and pain. Cold helps reduce swelling and numbs
deep pain. Using hot or cold packs may relieve pain, but this
treatment does not fix the cause of chronic back pain.
Exercise
Proper exercise can help ease chronic pain but should not be
used for acute back pain. Your doctor or physical therapist can
tell you the best types of exercise to do.
Medications
The following are the main types of medications used for back
pain:
- Analgesic medications are over-the-counter drugs such as
acetaminophen and aspirin or prescription pain medications.
- Topical analgesics are creams, ointments, and salves
rubbed onto the skin over the site of pain.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs
that reduce both pain and swelling. NSAIDs include
over-the-counter drugs such as ibuprofen, ketoprofen, and
naproxen sodium. Your doctor may prescribe stronger NSAIDs.
- Muscle relaxants and some antidepressants have also been
prescribed for chronic back pain, but it is not yet known if
they work for back pain.
Behavior Changes
You can learn to lift, push, and pull with less stress on
your back. Changing how you exercise, relax, and sleep can help
lessen back pain. Eating a healthy diet and not smoking also
help.
Injections
Your doctor may suggest steroid or numbing shots to lessen
your pain.
Complementary and Alternative Medical Treatments
When back pain becomes chronic or when other treatments do
not relieve it, some people try complementary and alternative
treatments. The most common of these treatments are:
- Manipulation. Professionals use their hands to adjust or
massage the spine or nearby tissues.
- Transcutaneous electrical nerve stimulation (TENS). A
small box over the painful area sends mild electrical pulses
to nerves. Studies have shown that TENS treatments are
not always effective for reducing pain.
- Acupuncture. This Chinese practice uses thin needles to
relieve pain and restore health. Acupunture may be effective
when used as a part of a comprehensive treatment plan for
low back pain.
- Acupressure. A therapist applies pressure to certain
places in the body to relieve pain. Acupressure has not
been well studied for back pain.
Surgery
Most people with chronic back pain do not need surgery. It is
usually used for chronic back pain if other treatments do not
work. You may need surgery if you have:
- Herniated disc. When one or more of the discs that
cushion the bones of the spine are damaged, the jelly-like
center of the disc leaks, causing pain.
- Spinal stenosis. This condition causes the spinal canal
to become narrow.
- Spondylolisthesis. This occurs when one or more bones of
the spine slip out of place.
- Vertebral fractures. A fracture can be caused by a blow
to the spine or by crumbling of the bone due to
osteoporosis.
- Degenerative disc disease. As people age, some have
discs that break down and cause severe pain.
Rarely, when back pain is caused by a tumor, an infection, or
a nerve root problem called cauda equina syndrome, surgery is
needed right away to ease the pain and prevent more problems.
What Kind of Research Is Being Done?
Back pain researchers are studying:
- Surgical versus nonsurgical treatment for back pain
- The best treatments for low back pain
- How well lumbar fusion surgery works for disc pain
- How often there are problems after lumbar fusion surgery
- Loss of movement and low back pain
- Ways for people with acute low back pain to feel better
- The role of nerves in low back pain
- Ways to use the Internet to teach people about back
pain.
Surce:
http://www.niams.nih.gov/Health_Info/Back_Pain/back_pain_ff.asp
Resources
http://www.cancer.gov/cancertopics/paincontrol/page1
TEST
Study this web-site for
3 hours for an
approved (RN-CEP 11430, MFT- PCE 39) 3-hours Continuing Education Certificate (0.3
CEUs).
Click
here for the self-correcting test & online payment, and 2) receive your
certificate immediately online. All is online, nothing by post-mail.
Consider taking another
LearnWell course.
|